IQVIA Holdings Inc. (LON: 0JDM)
London
· Delayed Price · Currency is GBP · Price in USD
204.11
+2.27 (1.12%)
Jan 23, 2025, 6:00 AM BST
IQVIA Holdings Revenue
IQVIA Holdings had revenue of $3.90B USD in the quarter ending September 30, 2024, with 4.28% growth. This brings the company's revenue in the last twelve months to $15.32B, up 3.10% year-over-year. In the year 2023, IQVIA Holdings had annual revenue of $14.98B with 3.98% growth.
Revenue (ttm)
$15.32B
Revenue Growth
+3.10%
P/S Ratio
n/a
Revenue / Employee
$176.03K
Employees
87,000
Market Cap
30.27B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
Dec 31, 2019 | 11.09B | 676.00M | 6.49% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
IQVIA Holdings News
- 19 days ago - How Is The Market Feeling About IQVIA Hldgs? - Benzinga
- 4 weeks ago - IQVIA Holdings Inc (IQV) Unveils Latest Digital Health Trends Report - GuruFocus
- 4 weeks ago - Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute - Business Wire
- 6 weeks ago - IQVIA Holdings: Share Price Disconnected From Growth Outlook - Seeking Alpha
- 2 months ago - IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024 - Business Wire
- 2 months ago - IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - IQVIA lowers annual revenue forecast amid trial delays - Reuters
- 3 months ago - IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day - Business Wire